Here, we have compiled five smartwatches for blood pressure tracking, great for the hypertensive who wants a convenient ...

All three regimens were well-tolerated, with no unexpected safety issues observed.

Net loss for the second quarter of 2025 was $19.4 million, or $0.50 per share, compared with a net loss of $16.0 million, or $0.45 per share, for the second quarter of 2024. Net loss for the second ...

Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capi ...